Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2014 Publisher: Phoenix Labs, Suite 12, Bunkilla Plaza, Bracetown Business Park, Clonee, Co. Meath, Ireland
Parvolex 200 mg/ml Concentrate for Solution for Infusion.
| Pharmaceutical Form |
|---|
|
Solution for infusion. Clear colourless solution contained in a 10 ml clear colourless Type I glass ampoule. |
Each ml contains Acetylcysteine 200mg.
Each 10 ml contains 322.6 mg of sodium.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Acetylcysteine |
Acetylcysteine is N-acetyl derivative of cysteine. Used as a mucolytic agent to reduce the viscosity of mucous secretions. |
| List of Excipients |
|---|
|
Disodium edetate |
Clear, Type I glass, 10ml snap ring ampoules. 10 × 10ml ampoules are packed in cartons.
Phoenix Labs, Suite 12, Bunkilla Plaza, Bracetown Business Park, Clonee, Co. Meath, Ireland
PL 35104/0011
14/10/1992 / 14/01/2003
| Drug | Countries | |
|---|---|---|
| PARVOLEX | Ireland, Malta, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
